Skip to main content
SpringerLink
Log in

Hyperforin and efficacy in animal models for anxiety and cognition

  • Chapter
St. John’s Wort and its Active Principles in Depression and Anxiety

Part of the book series: Milestones in Drug Therapy MDT ((MDT))

  • 980 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Daniel K (1935) Johanniskraut (Hypericum perforatum) bei psychischen Störungen. Hippokrates 14: 929–932

    Google Scholar 

  2. Müller WE, Kasper S (eds) (1997)A supplement of the journal. Pharmarmacopsychiatry 30(Suppl 2): 71–134

    Google Scholar 

  3. Chatterjee SS, Koch E, Nöldner M, Biber A, Erdelmeier C (1996) Hyperforin and Hypericum extracts: Interaction with some neurotransmitter systems. Phytomedicine 3(Suppl 1): 106

    Google Scholar 

  4. Chatterjee SS, Nöldner M, Koch E, Erdelmeier C (1998) Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry 31(Suppl 1): 7–15

    PubMed  Google Scholar 

  5. Greenshaw AJ (1993) Behavioural pharmacology of 5-HT3 receptor antagonists: A critical update on therapeutic potentials. TIPS 14: 265–270

    PubMed  Google Scholar 

  6. Eglen GR, Wong EHF, Dumuis A, Bockaert (1995) Central 5-HT4 receptors. TIPS 16: 391–398

    PubMed  Google Scholar 

  7. Müller WE, Chatterjee SS (eds) (1998) Hyperforin and the antidepressant activity of St John’s Wort. Pharmacopsychiatry 31(Suppl 1): 1–60

    Google Scholar 

  8. Müller WE, Chatterjee SS (eds): (2001) Biocentre symposium on drug therapy: Advances of St. John’s Wort research. Pharmacopsychiatry 34(Suppl 1): 1–156

    Google Scholar 

  9. De Vry J, Maurel S, Schreiber R, de Beun R, Jentzsch KR (1999) Comparison of Hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism. Eur Neuropsychopharmacol 9: 461–468

    Article  PubMed  Google Scholar 

  10. Panocka I, Perfumi M, Angeletti S, Ciccocioppo R, Massi M (2000) Effects of Hypericum perforatum extract on alcohol intake and on behavioral despair: A search for the neurochemical systems involved. Pharmacol Biochem Behav 66: 105–111

    Google Scholar 

  11. Perfumi M, Ciccocioppo R, Angeletti S, Cucculelli M, Massi M (1999) Effects of Hypericum perforatum extract on alcohol intake in Marchigian Sardinian alcohol-preferring rats. Alcohol Alcohol 34: 690–698

    PubMed  Google Scholar 

  12. Perfumi M, Panocka I, Ciccocioppo R, Vitali D, Froldi R, Massi M (2001) Effects of a methanolic extract and hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol Alcohol 36: 199–206

    PubMed  Google Scholar 

  13. Rezvani AH, Overstreet DH, Yang Y, Clark E Jr, (1999) Attenuation of alcohol intake by extract of Hypericum perforatum (St John’s Wort) in two different strains of alcohol-preferring rats. Alcohol Alcohol 34: 699–705

    PubMed  Google Scholar 

  14. Rezvani AH, Overstreet DH, Perfumi M, Massi M (2003) Plant derivatives in the treatment of alcohol dependency. Pharmacol Biochem Behav 75: 593–606

    Article  PubMed  Google Scholar 

  15. Simmen U, Burkard W, Berger K, Schaffner W, Lundstrom K (1999) Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system. J Recept Signal Transduct Res 19: 59–74

    PubMed  Google Scholar 

  16. Gobbi M, Moia M, Pirona L, Morazzoni P, Mennini T (2001) In vitro binding studies with two Hypericum perforatum extracts — hyperforin, hypericin and biapigenin — on 5-HT6, 5-HT7, GABAA/benzodiazepine, sigma, NPY-Y1/2 receptors and dopamine transporters. Pharmacopsychiatry 34(Suppl 1): S45–S48

    Article  PubMed  Google Scholar 

  17. Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J, Popadak B, Ernsberger P, Roth BL (2002) In vitro receptor screening of pure constituents of St. John’s Wort reveals novel interactions with a number of GPCRs. Psychopharmacology 162: 193–202

    Article  PubMed  Google Scholar 

  18. Klusa V, Germane S, Nöldner M, Chatterjee SS (2001) Hypericum extract and hyperforin: Memory-enhancing properties in rodents. Pharmacopsychiatry 34(Suppl 1): S61–S69

    PubMed  Google Scholar 

  19. Gambarana C, Tolu PL, Masi F, Rinaldi M, Giachetti D, Morazzoni P, De Montis MG (2001) A study of the antidepressant activity of Hypericum perforatum on animal models. Pharmacopsychiatry 34(Suppl 1): S42–S44

    PubMed  Google Scholar 

  20. Bhattacharya SK, Chakrabarti A, Chatterjee SS (1998) Activity profiles of two hyperforin-containing Hypericum extracts in behavioural models. Pharmacopsychiatry 31(Suppl 1): 22–29

    PubMed  Google Scholar 

  21. Müller WE, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry 31(Suppl 1): 16–21

    PubMed  Google Scholar 

  22. Coleta M, Campos MG, Cotrim MD, Porenca da Cunha A (2001) Comparative evaluation of Melissa officinalis L., Tilia europaea L., Passiflora edulis Sims. and Hypericum perforatum L. in the elevated plus maze anxiety test. Pharmacopsychiatry 34(Suppl 1): S20–S21

    PubMed  Google Scholar 

  23. Kumar V, Jaiswal AK, Singh PN, Bhattacharya SK (2000) Anxiolytic activity of Indian Hypericum perforatum Linn: An experimental study. Indian J Exp Biol 38: 36–41

    PubMed  Google Scholar 

  24. Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M (2000) Evidence that total extract of Hypericum perforatum affects exploratory behavior and exerts anxiolytic effects in rats. Pharmacol Biochem Behav 65: 627–633

    Article  PubMed  Google Scholar 

  25. Flausino OA Jr, Zangrossi H Jr, Salgado JV, Viana MB (2002) Effects of acute and chronic treatment with Hypericum perforatum L. (LI 160) on different anxiety-related responses in rats. Pharmacol Biochem Behav 71: 251–257

    Article  PubMed  Google Scholar 

  26. Beijamini V, Andreatini R (2003) Effects of Hypericum perforatum and paroxetine in the mouse defense test battery. Pharmacol Biochem Behav 74: 1015–1024

    Article  PubMed  Google Scholar 

  27. Beijamini V, Andreatini R (2003) Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze. Pharmacol Res 48: 199–207

    Article  PubMed  Google Scholar 

  28. Kumar V, Singh PN, Muruganandam AV, Bhattacharya SK (2000) Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction. J Ethnopharmacol 72: 119–128

    PubMed  Google Scholar 

  29. Kumar V, Khanna VK, Seth PK, Singh PN, Bhattacharya SK (2002) Brain neurotransmitter receptor binding and nootropic studies on Indian Hypericum perforatum Linn. Phytother Res 16: 210–216

    PubMed  Google Scholar 

  30. Khalifa A (2001) Hypericum perforatum as a nootropic drug: Enhancement of retrieval of memory of passive avoidance conditioning paradigm in mice. J Ethnopharmacol 76: 49–57

    PubMed  Google Scholar 

  31. Widy-Tyszkiewicz E, Piechal A, Joniec I, Blecharz-Klin K (2002) Long term administration of Hypericum perforatum improves spatial learning and memory in water maze. Biol Pharm Bull 25: 1289–1294

    PubMed  Google Scholar 

  32. Krishtal O, Lozovaya N, Fisunov A, Tsintsadze T, Pankratov Y, Kopanitsa M, Chatterjee SS (2001) Modulation of ion channels in rat neurons by the constituents of Hypericum perforatum. Pharmacopsychiatry 34(Suppl 1): S74–S82

    PubMed  Google Scholar 

  33. Keller JH, Karas M, Müller WE, Volmer DA, Eckert GP, Tawab MA, Blume HH, Dingermann T, Schubert-Zsilavecz M (2003) Determination of hyperforin in mouse brain by high-performance liquid chromatography/tandem mass spectrometry. Anal Chem 75: 6084–6088

    PubMed  Google Scholar 

  34. Singer A, Wonnemann M, Müller WE (1999) Hyperforin, a major antidepressant constituent of St. John’s Wort, inhibits serotonin uptake by elevating free intracellular Na+. J Pharmacol Exp Ther 290: 1363–1368

    PubMed  Google Scholar 

  35. Wonnemann M, Singer A, Müller WE (2000) Inhibition of synaptosomal uptake of 3H-L-glutamate and 3H-GABA by hyperforin, a major constituent of St. John’s Wort: The role of amiloride sensitive sodium conductance pathways. Neuropsychopharmacology 23: 188–197

    Article  PubMed  Google Scholar 

  36. Buchholzer ML, Dvorak C, Chatterjee SS, Klein J (2002) Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John’s Wort. J Pharmacol Exp Ther 301: 714–719

    PubMed  Google Scholar 

  37. Kiewert C, Buchholzer ML, Hartmann J, Chatterjee SS, Klein J (2004) Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John’s Wort. Neuroscience Lett 364: 195–198

    Google Scholar 

  38. Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer’s disease. Neuroscience 19: 1–28

    PubMed  Google Scholar 

  39. Gold PE (2003) Acetylcholine modulation of neural systems involved in learning and memory. Neurobiol Learn Memory 80: 194–201

    Google Scholar 

  40. Catania MA, Firenzuoli F, Crupi A, Mannucci C, Caputi AP, Calapi G (2003) Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacol 169: 186–189

    Google Scholar 

  41. Chatterjee SS, Erdelmeier C, Klessing K, Marme D, Schächtele C (1999) Stable hyperforin salts: Method of producing them and their uses in the treatment of Alzheimer’s disease. Int. Pat. PCT Wo 99/41220, August 19

    Google Scholar 

  42. Forestl B, Steiner B, Müller WE (2003) Enhancement of proteolytic processing of β-amyloid precursor protein by hyperforin. Biochem Pharmacol 66: 2177–2184

    PubMed  Google Scholar 

  43. Müller WE (2003) Current St. John’s Wort research from mode of action to clinical efficacy. Pharmacol Res 47: 101–109

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacology Laboratories, Research and Development Department, Dr. Willmar Schwabe GmbH & Co KG, Willmar-Schwabe-Straße 4, 76227, Karlsruhe, Germany

    Shyam S. Chatterjee

Authors
  1. Shyam S. Chatterjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut für Naturwissenschaftler, Biozentrum Universität Frankfurt, Marie-Curie-Str.9, 60439, Frankfurt, Germany

    Walter E. Müller

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag/Switzerland

About this chapter

Cite this chapter

Chatterjee, S.S. (2005). Hyperforin and efficacy in animal models for anxiety and cognition. In: Müller, W.E. (eds) St. John’s Wort and its Active Principles in Depression and Anxiety. Milestones in Drug Therapy MDT. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7338-5_8

Download citation

Publish with us

Policies and ethics

Search

Navigation